BlackRock Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

BlackRock Group’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$92K	Sell	925 -13,137	-93%	-$1.38M	﹤0.01%	2841
2016 Q3	$1.57M	Sell	14,062 -4,508	-24%	-$541K	﹤0.01%	1775
2016 Q2	$1.91M	Sell	18,570 -18	-0.1%	-$1.8K	﹤0.01%	1584
2016 Q1	$1.71M	Buy	18,588 +391	+2%	+$41.7K	﹤0.01%	1636
2015 Q4	$2.63M	Buy	18,197 +372	+2%	+$48.4K	﹤0.01%	1350
2015 Q3	$1.84M	Hold	17,825	–	–	﹤0.01%	1539
2015 Q2	$2.91M	Buy	+17,825	New	+$3.02M	﹤0.01%	1362

Other funds holding SIOX

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Group's SIOX Position: Q4 2016 in Review

BlackRock Group reduced its Sio Gene Therapies Inc. Common Stock (SIOX) stake by 93% in Q4 2016, selling an estimated $1.38M and leaving 925 shares worth $92K. The position accounts for ﹤0.01% of the portfolio, ranked #2841.

BlackRock Group first reported a position in SIOX in Q2 2015 and has held it in 7 quarters since. The position peaked at $2.91M in Q2 2015. 101 funds tracked by Wall St. Rank hold SIOX as of Q4 2016.

BlackRock Group held 925 shares of Sio Gene Therapies Inc. Common Stock worth $92K as of Q4 2016.
BlackRock Group sold 13,137 Sio Gene Therapies Inc. Common Stock shares in Q4 2016, an estimated $1.38M.
Sio Gene Therapies Inc. Common Stock made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2841 holding.
BlackRock Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and has held it in 7 quarters since.
BlackRock Group's Sio Gene Therapies Inc. Common Stock position peaked at $2.91M in Q2 2015.
101 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.